Ключевые слова:
mezenximal o‘zak hujayralar, ekzosomalar, sitokinlar, o‘sish omillari, regenerativ tibbiyot, hujayra terapiyasi, immunomodulyatsiya.Библиографические ссылки
A clinical study of mesenchymal stem cell exosomes nebulizer for the treatment of ARDS // https://classic.clinicaltrials.gov/ URL: https://classic.clinicaltrials.gov/ct2/show/results/ (accessed Ju ly 13, 2023).
A safety study of IV stem cell-derived extracellular vesicles (UNEX-42) in preterm neonates at high risk for BPD // https://classic.clinicaltrials. gov/ URL: https://classic.clinicaltrials.gov/ct2/sh-ow/NCT03857841 (accessed July 13, 2023).
Ando Y., et al. Stem cellconditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms // Bone 2014. P. 61.
Arslan F., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/ reperfusion injury. Stem Cell Res 2013;10. doi: https://doi.org/10. 1016/j.
Bai L., et al. Hepatocyte growth factor mediates MSCs stimulated functional recovery in animal models of MS // Nat Neurosci 2012. P. 12. doi: https: //doi.org/10.1038/
Barati S, Tahmasebi F, Faghihi F. Effects of mesenchymal stem cells transplantation on multiple sclerosis patients. Neuropeptides 2020. P. 84 doi: https://doi.org/10.1016/J.NPEP.2020.102095102095.
Bárcia RN., et al. Umbilical cord tissue–derived mesenchymal stromal cells maintain immunomodulatory and angiogenic potencies after cryopreservation and subsequent thawing // Cytotherapy 20 17. P. 360.
Bari E., et al. Mesenchymal stromal cell secretome for post-covid-19 pulmonary fibrosis: a new therapy to treat the long-term lung sequelae? Cells 2021. P.10. doi: https://doi.org/10.3390/cells10051 203.
Blazquez R., et al. Immunomodulatory potential of human adipose mesenchymal stem cells derived exosomes on in vitro stimulated T cells // Front Immunol 2014. P. 5. doi: https://doi.org/10.33 89/FIMMU.2014.00556/
Boese AC, Le QSE, Pham D, Hamblin MH, Lee JP. Neural stem cell therapy for subacute and chronic ischemic stroke // Stem Cell Res Ther 2018. P.154. doi: https://doi.org/10.1186/s13287-018-09 13-2.
Bone marrow mesenchymal stem cell derived extracellular vesicles infusion treatment for ARDS (EXIT-ARDS). // https:// classic.clinicaltrials. gov/ URL: https:// classic.clinicaltrials.gov/ct2/sh-ow/NCT05127122 (accessed July 13, 2023).
Camões SP., et al. 3D-MSCs A151 ODN-loaded exosomes are immunomodulatory and reveal a proteomic cargo that sustains wound resolution // J. Adv Res 2022. doi: https://doi.org/10.1016/j.jare. 2022.01.013.
Caplan AI, Correa D. The MSC: an injury drugstore // Cell Stem Cell 2011. P. 9-11. doi: https: //doi.org/10.1016/J.STEM.2011.06.008
Chen YX, Zeng ZC, Sun J, Zeng HY, Yan-Huang ZZY. Mesenchymal stem cellconditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells // J Radiat Res 2015. P. 56. doi: https: //doi.org/10.1093/JRR/RRV026.
Chouw A, Milanda T, Sartika CR, Kirana MN, Halim D, Faried A. Potency of mesenchymal stem cell and its secretome in treating COVID-19 // Regen Eng Transl Med 2021. P. 1–12. doi: https://doi.org/ 10.1007/s40883-021-00202-5.
Cofano F., et al. Mesenchymal stem cells for spinal cord injury: current options, limitations, and future of cell therapy // Int J Mol Sci 2019. P. 20. doi: https://doi.org/10.3390/IJMS201126982698
Conese M, Piro D, Carbone A, Castellani S, Di Gioia S. Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: Role of plasticity and heterogeneity // Sci World J 2014.
Cunningham CJ, Redondo-Castro E, Allan SM. The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke // J Cerebral Blood Flow Metab 2018. P. 92. doi: https://doi.org/ 10.1177/0271678X18776802.
Del F.A., et al. Immunoregulatory effects of mesenchymal stem cell-derived extracellular vesicles on T lymphocytes // Cell Transplant 2015. P. 26–27.
Dexter TM, Spooncer E. Growth and differentiation in the hemopoietic system // Annu Rev Cell Biol 1987. P. 41. doi: https://doi.org/10.1146/annurev.cb.03.110187.002231.
Dominici M., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement // Cytotherapy 2006. P.7. doi: https://doi. org/10.1080/14653240600855905.
Du Z., et al. Mesenchymal stem cell–conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation // J Surg Res 2013. P.15. doi: https://doi.org/10.101 6/J.JSS.2013.02.009.
Eleuteri S, Fierabracci A. Insights into the secretome of mesenchymal stem cells and its potential applications // Int J Mol Sci 2019. P. 20. doi: https://doi.org/10.3390/ijms201845974597.
English K, Barry FP, Field-Corbett CP, Mahon BP. IFN-c and TNF-a differentially regulate immunomodulation by murine mesenchymal stem cells // Immunol Lett 2007.P. 110. doi: https://doi.org/ 10.1016/J
Farfán N et al. Intranasal administration of mesenchymal stem cell secretome reduces hippocampal oxidative stress, neuroinflammation and cell death, improving the behavioral outcome following perinatal asphyxia // Int J Mol Sci 2020. P. 21: doi: https://doi.org/10.3390/ijms212078007800.
Ferguson SW., et al. The microRNA regulatory landscape of MSC-derived exosomes: a systems view // Sci Rep 2018. P. 1–12.
Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells // Cell Prolif. 1970. P. 393–403.
Fröhlich E. Therapeutic potential of mesenchymal stem cells andtheirproducts in lung diseases—intravenous administration versus inhalation // Pharmaceutics 2021. P. 13 22. doi: https:// doi.org/10.3390/pharmaceutics13020232.
Gilgenkrantz H, Collin de l’Hortet A. New insights into liver regeneration. Clin Res Hepatol Gastroenterol 2011.P. 35. doi: https://doi.org/10.10 16/J.
Gnecchi M., et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells // Nat Med 2005. P. 67.
Gu Y., et al. Endogenous IL-6 of mesenchymal stem cell improves behavioral outcome of hypoxic-ischemic brain damage neonatal rats by supressing apoptosis in astrocyte. Sci Rep 2016. P. 6. doi: https://doi.org/10.1038/srep18587.
Guo H, Huang B, Wang Y, Zhang Y, Ma Q, Ren Y. Bone marrow mesenchymal stem cells-derived exosomes improve injury of hippocampal neurons in rats with depression by upregulating microRNA-26a expression // Int Immunopharmacol 20 20. P. 82. doi: https://doi.org/10.1016/J.INTIMP.20 20.106285106285.
Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome // Cells 2019. P. 8
Islam O, Gong X, Rose-John S, Heese K. Interleukin-6 and neural stem cells: more than gliogenesis // Mol Biol Cell 2009. P. 99. doi: https://doi.org/ 10.1091/mbc.E08-05-0463
Katagiri W., et al. Angiogenesis in newly regenerated bone by secretomes of human mesenchymal stem cells // Maxillofac Plast Reconstr Surg 20 17. P. 39.
Katifelis H., et al. Amniotic fluid-derived mesenchymal stem/stromal cell derived secretome and exosomes improve inflammation in human intestinal subepithelial myofibroblasts // Biomedicines 2022. P. 10. doi: https://doi.org/10.3390/biomedicines10102357.
Kato T. Biological roles of hepatocyte growth factor-Met signaling from genetically modified animals. Biomed Rep 2017. P. 495–503. doi: https://doi.org/10.3892/BR.2017.1001.
Kim Y.H., et al. Conditioned medium from tonsil-derived mesenchymal stem cells relieves CCl 4-induced liver fibrosis in mice // Tissue Eng Regen Med 2018. P. 16. doi: https://doi.org/10.1007/S137 70-018-0160-8.
Lai RC, Chen TS, Lim SK. Mesenchymal stem cell exosome: a novel stem cellbased therapy for cardiovascular disease // Regener Med 2011. P. 81–92. doi: https://doi.org/10.2217/RME.11.35
Lee C., et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012. P. 126–11. doi: https://doi.org/10.1161/
Mancuso P, Raman S, Glynn A, Barry F, Murphy JM. Mesenchymal stem cell therapy for osteoarthritis: the critical role of the cell secretome. Front Bioeng Biotechnol 2019. P. 7. doi: https:// doi.org/10.3389/fbioe.2019.000099.
Marques CR, Marote A, Mendes-Pinheiro B, Teixeira FG, Salgado AJ. Cell secretome based approaches in Parkinson’s disease regenerative medicine // Expert Opin Biol Ther 2018. P. 45.
Meier R.P.H., et al. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice // J.Hepatol 2015. P. 41. doi: https://doi.org/ 10.1016/J.
Mendes-Pinheiro B., et al. Bone marrow mesenchymal stem cells’ secretome exerts neuroprotective effects in a Parkinson’s disease rat model // Front Bioeng Biotechnol 2019. P. 1. doi: https:// doi.org/10.3389/FBIOE.2019.00294294.
Mesenchymal stem cell secretome in severe cases of COVID-19 // https://classic.clinical-trials.gov/ URL: https://classic.clinicaltrials.gov/ct2 /show/NCT05122234 accessed July 13, 2023).
Miranda J.P., et al. The human umbilical cord tissue-derived MSC population UCX promotes early motogenic effects on keratinocytes and fibroblasts and CSFmediated mobilization of BM-MSCs when transplanted in vivo // Cell Transplant. 2015. P. 65–77. doi: https://doi.org/10.3727/096368913 X676231.
Monsel A, Zhu YG, Gennai S, Hao Q, Hu S, Rouby JJ, et al. Therapeutic effects of human mesenchymal stem cell-derived microvesicles in severe pneumonia in mice // Am J Respir Crit Care Med 2015. P. 192. doi: https://doi.org/10.1164/rccm.201 410-1765OC.
Monsel A, Zhu YG, Gudapati V, Lim H, Lee JW. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases // Expert Opin Biol Ther 2016. P. doi: https://doi.org/10.1517/14712598.20 16.1170804.
Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine // Exp Mol Med 2013. P. 45-48.
Nataliya B., et al. Mesenchymal stromal cells facilitate resolution of pulmonary fibrosis by miR-29c and miR-129 intercellular transfer // Exp Mol Med 2023. P. 122.
Noronha N., Mizukami A., et al. Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies // Stem Cell Res Ther 2019. P. 10. doi: https://doi.org/10.1186/s13287-019-1224-y.
Ohnishi S, Sumiyoshi H, Kitamura S, Nagaya N. Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions // FEBS Lett 2007. P. 581. doi: https://doi.org/10.1016/j
Oskowitz A, McFerrin H, Gutschow M, Carter ML, Pochampally R. Serumdeprived human multipotent mesenchymal stromal cells (MSCs) are highly angiogenic // Stem Cell Res 2011. 6. P. 25. doi: https://doi.org/10.1016/J.
Osugi M, Katagiri W, Yoshimi R, Inukai T, Hibi H, Ueda M. Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone defects. Tissue Eng Part A 2012. P. 18. doi: https://doi.org/10.1089/ten.tea.2011.0325.
Papait A., et al. Comparison of EV-free fraction, EVs, and total secretome of amniotic mesenchymal stromal cells for their immunomodulatory potential: a translational perspective // Front Immunol 2022. P. 13: doi: https://doi.org/10.3389/FIMMU.20 22.960909/BIBTEX960909.
Ping J., et al. Extracellular vesicles and their interplay with biological membrane // NTECHOPEN 2021. P. 78.
Pittenger MF, Discher DE, Péault BM, Phinney DG, Hare JM, Caplan AI. Mesenchymal stem cell perspective: cell biology to clinical progress // Npj Regene Med 2019. P. 1–15.
Reis M, Mavin E, Nicholson L, Green K, Dickinson AM, Wang XN. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function // Front Immunol 2018. P. 9: doi: https://doi.org/10.3389/FIMMU.2018.02538 /FULL2538.
Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives // Cells 2020. P. 9.
Romero-Gomez M. Biomarkers in detection, diagnosis and monitoring // Springer International Publishing; 2020. P. 147.
Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-c does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells // Clin Exp Immunol 2007. P. 149
Salgado A.J., et al. Mesenchymal stem cells secretome as a modulator of the neurogenic niche: basic insights and therapeutic opportunities // Front Cell Neurosci 2015. P. 9:.doi: https://doi.org/10.33 89/fncel.2015.00249249.
Santos J.M., et al. Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing // Stem Cell Res Ther 2015. P. 90. doi: https://doi.org/10.1186/s132 87-015-0082-5.
Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function // Stem Cell Res Ther 2016. P. 1–13.
The safety and the efficacy evaluation of allogenic adipose MSC-exos in patients with Alzheimer’s disease // https://classic.clinicaltrials.gov/ URL: https://classic.clinicaltrials.gov/ct2/show/ NCT04388982 (accessed July 13, 2023).
Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms // Am J Physiol Renal Physiol 2005. P. 289. doi: https:// doi.org/10.1152/ajprenal.00007.2005.
Tullis GE, Spears K, Kirk MD. Immunological barriers to stem cell therapy in the central nervous system // Stem Cells Int 2014. doi: https://doi. org/10.1155/2014/507905507905.
van Koppen A., et al. Human embryonic mesenchymal stem cell-derived conditioned medium rescues kidney function in rats with establi-shed chronic kidney disease // PLoS One 2012. P/ 7.
Varaa N, Azandeh S, Khodabandeh Z, Gharravi AM. Wharton’s jelly mesenchymal stem cell: various protocols for isolation and differentiation of hepatocyte-like cells; narrative review // Iran J Med Sci 2019. P. doi: https://doi.org/10.30476/IJMS.201 9.44952.
Vassileff N, Cheng L, Hill AF. Extracellular vesicles - Propagators of neuropathology and sources of potential biomarkers and therapeutics for neurodegenerative diseases // J Cell Sci 2020. P.133. doi: https://doi.org/10.1242/JCS.243139/226235.
Walker CL. Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis: pre-clinical evidence and potential for clinical application // Neural Regen Res 2019. P. 14.
Wang F, Tang H, Zhu J, Zhang JH. Transplanting mesenchymal stem cells for treatment of ischemic stroke // Cell Transplant 2018. P. 34. doi: https://doi.org/10.1177/0963689718795424.
Willis CM, Nicaise AM, Peruzzotti-Jametti L, Pluchino S. The neural stem cell secretome and its role in brain repair. Brain Res 2020. P. 54. doi: https://doi.org/10.1016/j.brainres.2019.146615146615.
Xagorari A., et al. Protective effect of mesenchymal stem cell-conditioned medium on hepatic cell apoptosis after acute liver injury // Int J Clin Exp Pathol 2013. P. 6
Xin H, Li Y, Chopp M. Exosomes/miRNAs as mediating cell-based therapy of strok // Front Cell Neurosci 2014. P.8. doi:https://doi.org/10.3389/fnc el.2014.00377.
Zagoura D., et al. Functional secretome analysis reveals Annexin-A1 as important paracrine factor derived from fetal mesenchymal stem cells in hepatic regeneration // EBioMedicine 2019.P. 52. doi: https://doi.org/10.1016/J.Zhang G-L, Zhu Z-H, Wang Y-Z. Neural stem cell transplantation therapy for brain ischemic stroke: review and perspectives // World J Stem Cells 2019. P. 30. doi: https://doi.org /10.4252/wjsc.v11.i10.817.
Zhang L, Ye C., et al. ADSCs stimulated by VEGF-Calleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-jB pathway by the secretome // Stem Cell 2022. P. 13.
Zheng J., et al. MSCs ameliorate hepatocellular apoptosis mediated by PINK1-dependent mitophagy in liver ischemia/reperfusion injury thro-ugh AMPKa activation // Cell Death Dis 2020. P. 11.